Published date: 7 March 2022

Last edited date: 7 March 2022

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 6 April 2022, 5pm

Contract summary

Industry

  • Pharmaceutical products - 33600000

  • Various medicinal products - 33690000

Location of contract

United Kingdom

Value of contract

£450,000

Procurement reference

CF-0681200D0O000000rwimUAA2

Published date

7 March 2022

Closing date

6 April 2022

Closing time

5pm

Contract start date

1 June 2022

Contract end date

31 May 2023

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

The Procurement relates to the supply of medical retinal vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England.

Period of framework: 1 June 2022 to 31 May 2023 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 24 months)

http://health.atamis.co.uk/

More information

Previous notice about this procurement

NHS Framework Agreement for the supply of Medical Retinal Vascular Treatments

  • Opportunity
  • Published 7 March 2022

About the buyer

Contact name

Mary-Jo Pryor

Address

80 London Road
London
SE1 6LH
GB

Email

mary-jo.pryor@nhs.net